Is The 100 Million Mouth Initiative Relevant To Kidney Disease?
This article reviews the 100 Million Mouth initiative and its possible relevance to kidney disease. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
All Resources
Depression & Anxiety In End-Stage Kidney Disease
This presentation will illuminate the burden of depression and anxiety in ESKD patients and the associated risk factors. Best practices and strategies for recognizing and discussing these concerns with patients… Read MoreUnderstanding Your Kidneys & Kidney Disease
This presentation focuses on the impact of kidney disease and autosomal dominant polycystic kidney disease (ADPKD) in Black and Hispanic/Latino communities and the effects of social determinants of health on… Read MoreThe Impact Of Kidney Disease & Disparities In Underserved Populations
This presentation will review the impact of kidney disease in the United States and the importance of the kidneys and preserving kidney function. Read MoreMental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
The goal of this presentation is to increase awareness surrounding the emotional and physical burden that ADPKD patients face. The presentation will also discuss the impact on patient’s caregivers as… Read MoreInfographic – Understanding Mental Health & Burnout For Health Care Professionals
This infographic reviews causative factors and consequences of burnout as well as ways to improve mental health and well-being in the workplace. Read MoreHow Health Plans Are Pursuing The Increasing Value Of Treating Kidney Disease
Due to the increasing value of chronic kidney disease treatments, this article reviews health plans’ current and potential spending priorities Read MoreInfographic – Racial & Ethnic Diversity In Clinical Trials: Overcoming Socioeconomic & Financial Barriers
Dive into our NephU resources! This infographic reviews some of the findings of racial and ethnic diversity and socioeconomic impart in clinical trials. Read MoreNew Autosomal Dominant Polycystic Kidney Disease Pain Assessment Tool
This article reviews some of the problems patients experience with pain, and a new pain assessment tool for ADPKD. Read MoreVoices From The Community Episode 25 – Chronic Kidney Disease & Depression Featuring Dr Shayan Shirazian
In this podcast, our host, Max Hyams, and Dr. Shirazian, will discuss the symptom overlap between chronic kidney disease and depression, how patients and healthcare providers can differentiate between the… Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
